The EMA published the following drafts of product-scientific guidelines regarding bioequivalence studies, which are currently open for public consultation:
…
EMA: Bioequivalence for enzalutamide, ibrutinib, liposomal amphotericin B, olaparid and ursodeoxycholic acid – Scientific guidelines 🇬🇧